526 related articles for article (PubMed ID: 16775010)
1. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
2. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification, and functional characterization of recombinant PTD-SARA.
Huang C; Du R; Zhang P; Meng H; Jia H; Song Y; Li M; Zhang Y; Sun S
Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):110-7. PubMed ID: 21266541
[TBL] [Abstract][Full Text] [Related]
4. Smad anchor for receptor activation (SARA) in TGF-beta signaling.
Tang WB; Ling GH; Sun L; Liu FY
Front Biosci (Elite Ed); 2010 Jun; 2(3):857-60. PubMed ID: 20515759
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
6. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB
J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
Tacheau C; Fontaine J; Loy J; Mauviel A; Verrecchia F
J Cell Physiol; 2008 Dec; 217(3):759-68. PubMed ID: 18668519
[TBL] [Abstract][Full Text] [Related]
8. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways.
Gunaratne A; Chan E; El-Chabib TH; Carter D; Di Guglielmo GM
J Cell Sci; 2015 Feb; 128(3):487–98. PubMed ID: 25501807
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells.
Li R; Wang Y; Liu Y; Chen Q; Fu W; Wang H; Cai H; Peng W; Zhang X
PLoS One; 2013; 8(3):e58848. PubMed ID: 23544048
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
11. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
12. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression.
Kunzmann S; Wohlfahrt JG; Itoh S; Asao H; Komada M; Akdis CA; Blaser K; Schmidt-Weber CB
FASEB J; 2003 Feb; 17(2):194-202. PubMed ID: 12554698
[TBL] [Abstract][Full Text] [Related]
13. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M; Shintani Y; Wheelock MJ; Johnson KR
J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
[TBL] [Abstract][Full Text] [Related]
14. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
15. Endofin acts as a Smad anchor for receptor activation in BMP signaling.
Shi W; Chang C; Nie S; Xie S; Wan M; Cao X
J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
[TBL] [Abstract][Full Text] [Related]
18. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN.
Sflomos G; Kostaras E; Panopoulou E; Pappas N; Kyrkou A; Politou AS; Fotsis T; Murphy C
J Cell Sci; 2011 Oct; 124(Pt 19):3209-22. PubMed ID: 21878490
[TBL] [Abstract][Full Text] [Related]
19. SARA is dispensable for functional TGF-β signaling.
Bakkebø M; Huse K; Hilden VI; Forfang L; Myklebust JH; Smeland EB; Oksvold MP
FEBS Lett; 2012 Sep; 586(19):3367-72. PubMed ID: 22819827
[TBL] [Abstract][Full Text] [Related]
20. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
Dong F; Liu T; Jin H; Wang W
Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
